Research & KnowledgeEvent: September 2, 2026
CureSHANK is participating in a clinical research study testing a novel at-home EEG device to study sleep in children with profound autism or cognitive impairment.
Published
Signal category
Research & Knowledge
Quote
“Testing a Novel Device to Study Sleep at Home in Children with Profound Autism”
— CureSHANK team
Company
CureSHANK
Relentlessly focused on turning promising science into life-transforming therapies for Phelan-McDermid syndrome.
- Industry
- Research Services
- Location
- Beverly Hills, US
- Company size
- 13 employees
CureSHANK is a nonprofit foundation whose mission is to accelerate the development of treatments for SHANK-associated disorders, specifically Phelan-McDermid Syndrome. Our approach is to identify and fund projects that overcome critical barriers to successful drug development and to coordinate scientific efforts to improve efficiency and speed in the field.
Founded 2019